Literature DB >> 20841473

Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression.

Andrew L Doedens1, Christian Stockmann, Mark P Rubinstein, Debbie Liao, Na Zhang, David G DeNardo, Lisa M Coussens, Michael Karin, Ananda W Goldrath, Randall S Johnson.   

Abstract

T cells can inhibit tumor growth, but their function in the tumor microenvironment is often suppressed. Many solid tumors exhibit abundant macrophage infiltration and low oxygen tension, yet how hypoxic conditions may affect innate immune cells and their role in tumor progression is poorly understood. Targeted deletion of the hypoxia-responsive transcription factor hypoxia-inducible factor-1α (HIF-1α) in macrophages in a progressive murine model of breast cancer resulted in reduced tumor growth, although vascular endothelial growth factor-A levels and vascularization were unchanged. Tumor-associated macrophages can suppress tumor-infiltrating T cells by several mechanisms, and we found that hypoxia powerfully augmented macrophage-mediated T-cell suppression in vitro in a manner dependent on macrophage expression of HIF-1α. Our findings link the innate immune hypoxic response to tumor progression through induction of T-cell suppression in the tumor microenvironment.
© 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20841473      PMCID: PMC2948598          DOI: 10.1158/0008-5472.CAN-10-1439

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

Authors:  Alessandra Mazzoni; Vincenzo Bronte; Alberto Visintin; Jessica H Spitzer; Elisa Apolloni; Paolo Serafini; Paola Zanovello; David M Segal
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

2.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 3.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

4.  Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway.

Authors:  J E Albina; W L Henry
Journal:  J Surg Res       Date:  1991-04       Impact factor: 2.192

5.  Nitric oxide-independent CTL suppression during tumor progression: association with arginase-producing (M2) myeloid cells.

Authors:  Yuanqing Liu; Jo A Van Ginderachter; Lea Brys; Patrick De Baetselier; Geert Raes; Anja B Geldhof
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

6.  Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.

Authors:  Paulo C Rodriguez; David G Quiceno; Jovanny Zabaleta; Blair Ortiz; Arnold H Zea; Maria B Piazuelo; Alberto Delgado; Pelayo Correa; Jason Brayer; Eduardo M Sotomayor; Scott Antonia; Juan B Ochoa; Augusto C Ochoa
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

7.  Inducible nitric oxide synthase in T cells regulates T cell death and immune memory.

Authors:  Monika Vig; Smita Srivastava; Usha Kandpal; Hadassah Sade; Virginia Lewis; Apurva Sarin; Anna George; Vineeta Bal; Jeannine M Durdik; Satyajit Rath
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.

Authors:  Elaine Y Lin; Joan G Jones; Ping Li; Liyin Zhu; Kathleen D Whitney; William J Muller; Jeffrey W Pollard
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 9.  L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

Authors:  Vincenzo Bronte; Paolo Serafini; Alessandra Mazzoni; David M Segal; Paola Zanovello
Journal:  Trends Immunol       Date:  2003-06       Impact factor: 16.687

10.  Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

Authors:  R J Barth; J J Mulé; P J Spiess; S A Rosenberg
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  274 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

3.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

4.  C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis.

Authors:  Facundo G Pelorosso; Allan Balmain
Journal:  EMBO J       Date:  2010-12-15       Impact factor: 11.598

5.  Low dose radiation primed iNOS + M1macrophages modulate angiogenic programming of tumor derived endothelium.

Authors:  Vinod Nadella; Sandhya Singh; Aklank Jain; Manju Jain; Karen M Vasquez; Ashok Sharma; Pranay Tanwar; Goura Kishore Rath; Hridayesh Prakash
Journal:  Mol Carcinog       Date:  2018-08-10       Impact factor: 4.784

6.  Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.

Authors:  Devikala Gurusamy; Jerilyn K Gray; Peterson Pathrose; Rishikesh M Kulkarni; Fred D Finkleman; Susan E Waltz
Journal:  Cancer Res       Date:  2013-01-17       Impact factor: 12.701

Review 7.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

8.  Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD.

Authors:  Xiaofang Huo; Agoston T Agoston; Kerry B Dunbar; Daisha J Cipher; Xi Zhang; Chunhua Yu; Edaire Cheng; Qiuyang Zhang; Thai H Pham; Uttam K Tambar; Richard K Bruick; David H Wang; Robert D Odze; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2016-09-30       Impact factor: 23.059

Review 9.  Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity.

Authors:  John D Martin; Dai Fukumura; Dan G Duda; Yves Boucher; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2016-12-01       Impact factor: 6.915

10.  Hypoxia-inducible factors: a central link between inflammation and cancer.

Authors:  Daniel Triner; Yatrik M Shah
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.